Related Experiment Video
Updated: Apr 23, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Fabry disease in infancy and early childhood: a systematic literature review
Dawn A Laney1, Dawn S Peck2, Andrea M Atherton3
1Division of Medical Genetics, Department of Human Genetics, Decatur, Georgia, USA.
Insights
Fabry disease symptoms, including neuropathic pain and gastrointestinal issues, can appear before age five in children. Early detection and specialist referral are crucial for managing this genetic disorder.
Area of Science:
- Genetics
- Pediatrics
- Lysosomal Storage Disorders
Background:
- Fabry disease is a progressive, X-linked genetic disorder caused by alpha-galactosidase A deficiency.
- While symptoms in older children are documented, data for infants and early childhood are limited.
Purpose of the Study:
- To identify the age of symptom onset for specific manifestations of Fabry disease in early childhood.
- To delineate the early clinical presentation of Fabry disease in pediatric patients.
Main Methods:
- Systematic retrospective analysis of PubMed-indexed publications and case reports.
- Focused on pediatric Fabry disease patients under five years of age.
Main Results:
- Acroparesthesias/neuropathic pain were the most frequent symptom (9 children, ages 2.0-4.0 years).
- Gastrointestinal issues were also notable (6 children, ages 1.0-4.1 years).
Conclusions:
- Symptoms of Fabry disease can manifest in early childhood, prior to age five.
- Timely referral to specialists experienced in pediatric Fabry disease management is strongly indicated.
Purpose:
Fabry disease is a pan-ethnic, progressive, X-linked genetic disorder that commonly presents in childhood and is caused by deficient activity of the lysosomal enzyme alpha-galactosidaseA (α-gal A). Symptoms of Fabry disease in the pediatric population are well described for patients over five years of age; however, data are limited for infancy and early childhood. The purpose of this article is to delineate the age of detection for specific Fabry symptoms in early childhood.
Methods:
A systematic retrospective analysis of PubMed indexed, peer-reviewed publications and case reports in the pediatric Fabry population was performed to review symptoms in patients reported before 5 years of age.
Results:
The most frequently reported symptom in all age groups under 5 years was acroparesthesias/neuropathic pain, reported in 9 children, ranging in age from 2.0-4.0 years. Also notable is the frequency of gastrointestinal issues reported in 6 children aged 1.0-4.1 years of age.
Conclusion:
This article finds clear evidence that symptoms can occur in early childhood, before age 5 years. Given early presenting symptoms and the ability to monitor these disease hallmarks, a timely referral to a medical geneticist or other specialty clinician experienced in managing children with Fabry disease is strongly indicated.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Related Concept Videos
Lysosomal Hydrolases
Cystic Fibrosis: Management
Sinus disease and chronic...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...